McKesson Corporation (MCK)
Last closing price (Mar 06 4:00 EDT):
182.58 (0.34%) ?
McKesson Corporation, together with its subsidiaries, delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry primarily in the United States. It operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs, medical-surgical supplies and equipment, and health and beauty care products in North America. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers; and practice management, technology, clinical support, and business solutions to oncology and other specialty practices operating in the community setting. In addition, this segment sells financial, operational, and clinical solutions for retail, hospital, and alternate site pharmacies; and provides consulting and outsourcing services. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions, as well as pharmacy automation solutions for hospitals; and connectivity, claims processing, outsourcing, and other services, including remote hosting and managed services to healthcare organizations. This segment also offers InterQual clinical criteria solution, claims payment solutions, and network performance tools. This segments customers include hospitals, physicians, homecare providers, retail pharmacies, and payers in North America, the United Kingdom, Ireland, other European countries, and Israel. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
|Ann Hynes||Mizuho Securities USA||Buy||Mar 03, '14||176.05||199.00||Mar 03, '15||3.71%|
|Robert Jones||Goldman Sachs||Buy||Feb 19, '14||177.42||Feb 19, '15||2.91%|
|Lisa Gill||JPMorgan||Buy||Feb 07, '14||174.75||Feb 07, '15||4.48%|
|Ross Muken||ISI Group||Buy||Jan 31, '14||174.17||203.00||Jan 31, '15||4.83%|
|Alexander Draper||Raymond James||Buy||Jan 06, '14||160.04||Jan 06, '15||14.08%|
|Charles Rhyee||Cowen And Company||Buy||Oct 25, '13||154.55||173.00||Oct 25, '14||18.14%|
|Ricky Goldwasser||Morgan Stanley||Buy||Oct 25, '13||154.55||Oct 25, '14||18.14%|
|David Larsen||Leerink Swann Llc||Buy||Oct 24, '13||149.58||Oct 24, '14||22.06%|
|Ross Muken||ISI Group||Buy||Oct 14, '13||138.30||152.00||Oct 14, '14||32.02%|
|John Ransom||Raymond James||Buy||Oct 09, '13||133.10||Oct 09, '14||37.18%|
|Alexander Draper||Raymond James||Buy||Oct 09, '13||133.10||Oct 09, '14||37.18%|
|Eric Coldwell||Robert W. Baird & Co., Inc.||Buy||Oct 01, '13||131.15||150.00||Oct 01, '14||39.21%|
|Eric Coldwell||Robert W. Baird & Co., Inc.||Buy||Jul 17, '13||117.49||130.00||Jul 17, '14||55.40%|
|Tom Gallucci||Lazard Capital Markets||Buy||Jul 17, '13||117.49||136.00||Jul 17, '14||55.40%|
|Lisa Gill||JPMorgan||Buy||Jun 27, '13||115.01||Jun 27, '14||58.75%|
|Charles Rhyee||Cowen And Company||Buy||May 08, '13||115.35||May 08, '14||58.28%|
|Glen Santangelo||Credit Suisse||Buy||May 08, '13||115.35||May 08, '14||58.28%|
|George Hill||Citi||Buy||May 08, '13||115.35||May 08, '14||58.28%|
|Robert Jones||Goldman Sachs||Buy||Mar 20, '13||106.35||Mar 20, '14||71.68%|
|Tom Gallucci||Lazard Capital Markets||Buy||Mar 04, '13||106.68||122.00||Mar 04, '14||65.03%|